We are live on ! Find out more
SRIM

Saratoga Research & Investment Management Portfolio holdings

AUM $1.83B
1-Year Est. Return 18.41%
This Fund
S&P 500
This Quarter Est. Return
+7.81%
1 Year Est. Return
+18.41%
3 Year Est. Return
+54.35%
5 Year Est. Return
+69.05%
10 Year Est. Return
+285.04%
AUM
$1.2B
AUM Growth
+$97.8M
Cap. Flow
+$14.8M
Cap. Flow %
1.23%
Top 10 Hldgs %
53.81%
Holding
47
New
2
Increased
14
Reduced
23
Closed
1

Top Sells

Rank Stock Value
1
VAR
Varian Medical Systems, Inc.
VAR
+$5.89M
2
MSFT icon
Microsoft
MSFT
+$3.69M
3
BDX icon
Becton Dickinson
BDX
+$2.61M
4
ACN icon
Accenture
ACN
+$2.07M
5
MDT icon
Medtronic
MDT
+$1.78M

Sector Composition

Rank Sector Weight
1 Technology 34.86%
2 Industrials 17.35%
3 Healthcare 15.55%
4 Consumer Staples 14.52%
5 Consumer Discretionary 5.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
1
Apple
AAPL
$4.5T
$95.8M 7.96%
2,668,528
+16,548
+0.6% +$545K
MSFT icon
2
Microsoft
MSFT
$3.76T
$74.8M 6.22%
1,136,290
-57,598
-5% -$3.69M
ORCL icon
3
Oracle
ORCL
$435B
$72.9M 6.06%
1,635,147
+25,944
+2% +$1.08M
RTX icon
4
RTX Corp
RTX
$302B
$67.6M 5.61%
957,026
+33,504
+4% +$2.35M
WMT icon
5
Walmart Inc
WMT
$897B
$64.5M 5.36%
2,685,303
+70,923
+3% +$1.63M
CSCO icon
6
Cisco
CSCO
$483B
$63.8M 5.3%
1,887,885
-30,967
-2% -$1M
BRK.B icon
7
Berkshire Hathaway Class B
BRK.B
$1.13T
$59.9M 4.97%
359,083
+21,740
+6% +$3.64M
CHRW icon
8
C.H. Robinson
CHRW
$17.3B
$53.4M 4.44%
691,178
+2,319
+0.3% +$178K
NVO
9
Novo Nordisk
NVO
$209B
$47.9M 3.98%
2,792,402
+254,872
+10% +$4.44M
PG icon
10
Procter & Gamble
PG
$340B
$47.2M 3.92%
525,571
-15,492
-3% -$1.37M
VAR
11
DELISTED
Varian Medical Systems, Inc.
VAR
$42.7M 3.55%
468,663
-70,587
-13% -$5.89M
CTSH icon
12
Cognizant
CTSH
$26.3B
$42M 3.49%
706,070
+49,027
+7% +$2.82M
BDX icon
13
Becton Dickinson
BDX
$48.9B
$39.1M 3.25%
218,398
-14,952
-6% -$2.61M
IBM icon
14
IBM
IBM
$223B
$37.4M 3.1%
224,372
-557
-0.2% -$93.4K
EXPD icon
15
Expeditors International
EXPD
$23.3B
$35.7M 2.96%
631,708
+70,712
+13% +$3.88M
BIIB icon
16
Biogen
BIIB
$30.6B
$34.5M 2.87%
126,222
+5,896
+5% +$1.67M
MMM icon
17
3M
MMM
$93.9B
$33.6M 2.79%
210,075
-11,577
-5% -$1.78M
JNJ icon
18
Johnson & Johnson
JNJ
$631B
$33.4M 2.77%
267,978
-4,673
-2% -$558K
ACN icon
19
Accenture
ACN
$109B
$32.1M 2.67%
267,780
-17,310
-6% -$2.07M
MDT icon
20
Medtronic
MDT
$114B
$31.5M 2.61%
390,470
-22,741
-6% -$1.78M
PEP icon
21
PepsiCo
PEP
$188B
$31.4M 2.61%
280,908
-6,898
-2% -$740K
KO icon
22
Coca-Cola
KO
$374B
$30.7M 2.55%
723,520
-18,742
-3% -$782K
PII icon
23
Polaris
PII
$3.97B
$24.5M 2.03%
292,349
-11,802
-4% -$1.02M
NKE icon
24
Nike
NKE
$62.5B
$24M 2%
431,113
+6,000
+1% +$331K
GOOGL icon
25
Alphabet (Google) Class A
GOOGL
$4.37T
$18.7M 1.55%
440,680
+103,660
+31% +$4.36M

Similar funds

Saratoga Research & Investment Management's Q1 2017 Portfolio in Review

As of Q1 2017, Saratoga Research & Investment Management held 47 positions worth $1.2B, up 8.8% from $1.11B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Saratoga Research & Investment Management's Q1 2017 filing shows 2 new, 14 increased, 23 reduced and 1 closed positions. Its largest new stake was Enbridge: 7,411 shares worth $310K. The largest sale was Varian Medical Systems, Inc., an estimated $5.89M.

By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 34% a quarter earlier, followed by Industrials and Healthcare.

  • Saratoga Research & Investment Management's largest Q1 2017 buy was Enbridge: 7,411 shares worth $310K.
  • Saratoga Research & Investment Management added most to Starbucks in Q1 2017, an estimated $11.9M increase.
  • Saratoga Research & Investment Management's biggest Q1 2017 reduction was Varian Medical Systems, Inc., cutting an estimated $5.89M.
  • Saratoga Research & Investment Management fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $310K.
  • Saratoga Research & Investment Management's ten largest holdings make up 54% of its $1.2B portfolio in Q1 2017.
  • Saratoga Research & Investment Management opened 2 new positions and closed 1 in Q1 2017.
  • Saratoga Research & Investment Management's portfolio value rose 8.8% quarter-over-quarter to $1.2B.

Based on Saratoga Research & Investment Management's 13F filing for Q1 2017, filed 28 Apr 2017.